US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Beyondspring Inc

0.7700

-0.0033-0.43%

Volume:268.86K

Turnover:212.77K

Market Cap:31.66M

PE:-4.70

High:0.8498

Open:0.7000

Low:0.7000

Close:0.7733

52wk High:2.44

52wk Low:0.5657

Shares:41.12M

Float Shares:31.95M

Volume Ratio:0.13

T/O Rate:0.84%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1638

EPS(LYR):-0.0249

ROE:-310.48%

ROA:-22.86%

PB:-0.89

PE(LYR):-30.93

Loading ...

Overview Company News Filings

Beyondspring - Appoints Na Li as Chief Financial Officer

THOMSON REUTERS

Beyondspring - Appoints Min Qiu as Chief Executive Officer

THOMSON REUTERS

Beyondspring - Lan Huang Remains Chairman of Beyondspring, Focuses Executive Duties on Seed Therapeutics

THOMSON REUTERS

Beyondspring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory Dublin-4 Program and Long-Term Value

THOMSON REUTERS

Press Release: BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

BeyondSpring publishes corporate deck highlighting plinabulin immune-modulating cancer therapy pipeline

Beyondspring - Reports 12-Month Os Rate of 78.1%, 24-Month Os Rate of 58% in Phase 2 Nsclc Study

THOMSON REUTERS

Beyondspring - 53.2% of Patients Experienced Grade 3 or Higher Adverse Events in Phase 2 Nsclc Study

THOMSON REUTERS

Beyondspring - Reports Median Pfs of 7 Months, Dcr of 79.5% in Phase 2 Nsclc Study

THOMSON REUTERS

BeyondSpring says Phase 2 trial shows 7-month median PFS for pembrolizumab plus plinabulin/docetaxel in post-ICI metastatic NSCLC

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

BeyondSpring to present Phase 2 plinabulin combo study in resistant NSCLC at ASCO 2026

BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting

BeyondSpring Q1 EPS $(0.05) Up From $(0.06) YoY

Benzinga Earnings

BeyondSpring Q1 FY26 net loss narrows to $2.4 million

BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update

BeyondSpring publishes corporate presentation on plinabulin immune-modulating cancer therapy pipeline

BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BYSI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BYSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BYSI\",,,,,undefined,":{"symbol":"BYSI","market":"US","secType":"STK","nameCN":"Beyondspring Inc","latestPrice":0.77,"timestamp":1790798400000,"preClose":0.7733,"halted":0,"volume":268862,"delay":0,"changeRate":-0.0042674253200568595,"floatShares":31950100,"shares":41122299,"eps":-0.163815,"marketStatus":"Pre-Mkt","change":-0.0033,"latestTime":"10-01 05:08:57 EDT","open":0.7,"high":0.8498,"low":0.7,"amount":212770.66525000002,"amplitude":0.193715,"askPrice":0.8684,"askSize":100,"bidPrice":0.708,"bidSize":43,"shortable":3,"etf":0,"ttmEps":-0.163815,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1489035600000,"exchange":"NASDAQ","adjPreClose":0.77,"postHourTrading":{"tag":"盘后","latestPrice":0.7672,"preClose":0.77,"latestTime":"19:58 EDT","volume":3629,"amount":2915.8405,"timestamp":1790812704042,"change":-0.0028,"changeRate":-0.003636,"amplitude":0.107273},"volumeRatio":0.12601619308623915,"impliedVol":0.4474,"impliedVolPercentile":0.94},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BYSI\",,,,,undefined,":{"symbol":"BYSI","floatShares":31950100,"roa":"-22.86%","roe":"-310.48%","lyrEps":-0.024897,"volumeRatio":0.12601619308623915,"shares":41122299,"dividePrice":0,"high":0.8498,"amplitude":0.193715,"preClose":0.7733,"low":0.7,"week52Low":0.5657,"pbRate":"-0.89","psRate":"16.88","week52High":2.44,"institutionHeld":0,"latestPrice":0.77,"committee":-0.398601,"eps":-0.163815,"divideRate":0,"volume":268862,"delay":0,"ttmEps":-0.163815,"open":0.7,"prevYearClose":1.63,"prevWeekClose":0.7772,"prevMonthClose":0.77,"prevQuarterClose":0.77,"fiveDayClose":0.7266,"twentyDayClose":0.6026,"sixtyDayClose":1.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BYSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"BYSI","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2026-05-13","symbol":"BYSI","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.05},{"date":"2026-03-25","symbol":"BYSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774425600000,"name":null,"time":"Pre-MKt","dateTimestamp":1774411200000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"BYSI","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-08-13","symbol":"BYSI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BYSI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BYSI\",market:\"US\",delay:true,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BYSI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"BYSI","date":"2026-09-29","current":-4.700424,"percent":0.273676,"low":-161.60109,"twenty":-19.691837,"median":-3.86717,"eighty":-1.061308,"high":-0.342396,"avg":-17.104686,"sd":32.514312,"marketCap":46054198},"quantilePoints":[{"date":"2021-10-01","current":-8.796806,"twenty":-11.414906,"median":-8.784917,"eighty":-7.280852,"marketCap":601983051},{"date":"2021-10-08","current":-8.551022,"twenty":-11.373288,"median":-8.775305,"eighty":-7.283325,"marketCap":585163511},{"date":"2021-10-15","current":-9.459853,"twenty":-11.349009,"median":-8.782183,"eighty":-7.290009,"marketCap":647356692},{"date":"2021-10-22","current":-9.139762,"twenty":-11.329516,"median":-8.789263,"eighty":-7.2923,"marketCap":625452175},{"date":"2021-10-29","current":-7.899406,"twenty":-11.307631,"median":-8.784917,"eighty":-7.297158,"marketCap":540572174},{"date":"2021-11-05","current":-8.676772,"twenty":-11.307631,"median":-8.784707,"eighty":-7.297158,"marketCap":593768857},{"date":"2021-11-12","current":-8.459567,"twenty":-11.300335,"median":-8.777482,"eighty":-7.330781,"marketCap":578905078},{"date":"2021-11-19","current":-7.573599,"twenty":-11.300335,"median":-8.774324,"eighty":-7.333884,"marketCap":518276506},{"date":"2021-11-26","current":-8.20235,"twenty":-11.294499,"median":-8.764743,"eighty":-7.333263,"marketCap":561303234},{"date":"2021-12-03","current":-2.297801,"twenty":-11.29304,"median":-8.74476,"eighty":-7.297158,"marketCap":157243136},{"date":"2021-12-10","current":-2.389256,"twenty":-11.279239,"median":-8.735735,"eighty":-7.28283,"marketCap":163501569},{"date":"2021-12-17","current":-2.617893,"twenty":-11.184539,"median":-8.732706,"eighty":-7.274397,"marketCap":179147652},{"date":"2021-12-23","current":-2.812234,"twenty":-11.15548,"median":-8.724843,"eighty":-7.260231,"marketCap":192446823},{"date":"2021-12-31","current":-2.453771,"twenty":-11.148807,"median":-8.714589,"eighty":-7.243476,"marketCap":177314406},{"date":"2022-01-07","current":-2.453771,"twenty":-11.125249,"median":-8.713986,"eighty":-7.235633,"marketCap":177314406},{"date":"2022-01-14","current":-2.101685,"twenty":-11.106282,"median":-8.69392,"eighty":-7.22882,"marketCap":151871941},{"date":"2022-01-21","current":-1.776682,"twenty":-11.102292,"median":-8.693667,"eighty":-7.22195,"marketCap":128386589},{"date":"2022-01-28","current":-1.630431,"twenty":-11.090084,"median":-8.682709,"eighty":-7.20706,"marketCap":117818181},{"date":"2022-02-04","current":-1.662931,"twenty":-11.062511,"median":-8.676855,"eighty":-7.172414,"marketCap":120166716},{"date":"2022-02-11","current":-1.608764,"twenty":-11.029242,"median":-8.675168,"eighty":-7.155129,"marketCap":116252491},{"date":"2022-02-18","current":-1.435429,"twenty":-11.005487,"median":-8.659624,"eighty":-7.143917,"marketCap":103726970},{"date":"2022-02-25","current":-1.365012,"twenty":-11.004497,"median":-8.641816,"eighty":-7.109794,"marketCap":98638477},{"date":"2022-03-04","current":-1.077926,"twenty":-10.998539,"median":-8.624931,"eighty":-7.072868,"marketCap":77893083},{"date":"2022-03-11","current":-1.007509,"twenty":-10.983171,"median":-8.613897,"eighty":-7.046745,"marketCap":72804590},{"date":"2022-03-18","current":-1.251261,"twenty":-10.963416,"median":-8.59976,"eighty":-6.999757,"marketCap":90418604},{"date":"2022-03-25","current":-1.20251,"twenty":-10.956482,"median":-8.596563,"eighty":-6.97543,"marketCap":86895801},{"date":"2022-04-01","current":-1.300011,"twenty":-10.947277,"median":-8.592937,"eighty":-6.930407,"marketCap":93941407},{"date":"2022-04-08","current":-1.283761,"twenty":-10.934968,"median":-8.577836,"eighty":-6.887865,"marketCap":92767139},{"date":"2022-04-14","current":-1.328337,"twenty":-10.931928,"median":-8.571023,"eighty":-6.881827,"marketCap":85251362},{"date":"2022-04-22","current":-1.182766,"twenty":-10.874867,"median":-8.55388,"eighty":-6.862586,"marketCap":75908747},{"date":"2022-04-29","current":-0.921951,"twenty":-10.869132,"median":-8.543875,"eighty":-6.844639,"marketCap":59169895},{"date":"2022-05-06","current":-0.97654,"twenty":-10.799881,"median":-8.518237,"eighty":-6.824288,"marketCap":62673376},{"date":"2022-05-13","current":-0.758183,"twenty":-10.793266,"median":-8.475943,"eighty":-6.802132,"marketCap":48659453},{"date":"2022-05-20","current":-0.782445,"twenty":-10.757701,"median":-8.440174,"eighty":-6.794418,"marketCap":50216556},{"date":"2022-05-27","current":-0.800642,"twenty":-10.666331,"median":-8.417431,"eighty":-6.777322,"marketCap":51384383},{"date":"2022-06-03","current":-0.964409,"twenty":-10.593851,"median":-8.40388,"eighty":-6.766317,"marketCap":61894825},{"date":"2022-06-10","current":-1.073588,"twenty":-10.535211,"median":-8.379544,"eighty":-6.743515,"marketCap":68901786},{"date":"2022-06-17","current":-0.8431,"twenty":-10.485959,"median":-8.340934,"eighty":-6.72321,"marketCap":54109312},{"date":"2022-06-24","current":-0.8431,"twenty":-10.428365,"median":-8.316315,"eighty":-6.693158,"marketCap":54109312},{"date":"2022-07-01","current":-0.946213,"twenty":-10.400502,"median":-8.301716,"eighty":-6.672201,"marketCap":60726998},{"date":"2022-07-08","current":-1.09785,"twenty":-10.388718,"median":-8.29285,"eighty":-6.654109,"marketCap":70458889},{"date":"2022-07-15","current":-0.970475,"twenty":-10.36542,"median":-8.27886,"eighty":-6.644132,"marketCap":62284100},{"date":"2022-07-22","current":-0.8431,"twenty":-10.301418,"median":-8.238859,"eighty":-6.618151,"marketCap":54109312},{"date":"2022-07-29","current":-0.8431,"twenty":-10.252094,"median":-8.216736,"eighty":-6.607281,"marketCap":54109312},{"date":"2022-08-05","current":-0.915886,"twenty":-10.210516,"median":-8.20235,"eighty":-6.590159,"marketCap":58780620},{"date":"2022-08-12","current":-0.964409,"twenty":-10.173794,"median":-8.18979,"eighty":-6.556471,"marketCap":61894825},{"date":"2022-08-19","current":-0.946213,"twenty":-10.154544,"median":-8.161715,"eighty":-6.517533,"marketCap":60726998},{"date":"2022-08-26","current":-0.806707,"twenty":-10.091811,"median":-8.14509,"eighty":-6.480049,"marketCap":51773658},{"date":"2022-09-02","current":-0.770314,"twenty":-10.001482,"median":-8.100262,"eighty":-6.450482,"marketCap":49438005},{"date":"2022-09-09","current":-0.940147,"twenty":-9.993794,"median":-8.075287,"eighty":-6.419817,"marketCap":60337722},{"date":"2022-09-16","current":-0.830969,"twenty":-9.971244,"median":-8.054429,"eighty":-6.391117,"marketCap":53330761},{"date":"2022-09-23","current":-0.64294,"twenty":-9.950155,"median":-8.021655,"eighty":-6.338172,"marketCap":41263216},{"date":"2022-09-30","current":-0.600481,"twenty":-9.913473,"median":-8.015173,"eighty":-6.301074,"marketCap":38538287},{"date":"2022-10-07","current":-0.590595,"twenty":-9.889115,"median":-7.97709,"eighty":-6.254861,"marketCap":37903768},{"date":"2022-10-14","current":-0.521812,"twenty":-9.850961,"median":-7.945258,"eighty":-6.207183,"marketCap":33489382},{"date":"2022-10-21","current":-0.491849,"twenty":-9.81876,"median":-7.926159,"eighty":-6.166303,"marketCap":31566360},{"date":"2022-10-28","current":-0.485237,"twenty":-9.793262,"median":-7.900693,"eighty":-6.152974,"marketCap":31142050},{"date":"2022-11-04","current":-0.441141,"twenty":-9.758343,"median":-7.867886,"eighty":-6.122096,"marketCap":28312016},{"date":"2022-11-11","current":-0.424583,"twenty":-9.733956,"median":-7.829624,"eighty":-6.083665,"marketCap":27249294},{"date":"2022-11-18","current":-0.387401,"twenty":-9.705595,"median":-7.81793,"eighty":-5.903749,"marketCap":24863034},{"date":"2022-11-25","current":-0.361684,"twenty":-9.686755,"median":-7.810813,"eighty":-5.7831,"marketCap":23212505},{"date":"2022-12-02","current":-0.347127,"twenty":-9.682822,"median":-7.771856,"eighty":-2.793943,"marketCap":22278244},{"date":"2022-12-09","current":-0.369994,"twenty":-9.682822,"median":-7.746125,"eighty":-2.621323,"marketCap":23745813},{"date":"2022-12-16","current":-1.382927,"twenty":-9.682822,"median":-7.73971,"eighty":-2.570308,"marketCap":88754843},{"date":"2022-12-23","current":-1.025064,"twenty":-9.677099,"median":-7.719207,"eighty":-2.463076,"marketCap":65787581},{"date":"2022-12-30","current":-1.140308,"twenty":-9.677099,"median":-7.706017,"eighty":-2.431933,"marketCap":73183818},{"date":"2023-01-06","current":-1.055391,"twenty":-9.677099,"median":-7.684438,"eighty":-2.36321,"marketCap":67733959},{"date":"2023-01-13","current":-1.29801,"twenty":-9.677099,"median":-7.671666,"eighty":-2.219355,"marketCap":83304984},{"date":"2023-01-20","current":-1.516367,"twenty":-9.677099,"median":-7.671666,"eighty":-1.914266,"marketCap":97318907},{"date":"2023-01-27","current":-1.534563,"twenty":-9.670972,"median":-7.643672,"eighty":-1.765848,"marketCap":98486734},{"date":"2023-02-03","current":-1.637676,"twenty":-9.670972,"median":-7.624089,"eighty":-1.683515,"marketCap":105104420},{"date":"2023-02-10","current":-1.352599,"twenty":-9.670972,"median":-7.620572,"eighty":-1.662931,"marketCap":86808465},{"date":"2023-02-17","current":-1.23129,"twenty":-9.670972,"median":-7.620572,"eighty":-1.623166,"marketCap":79022952},{"date":"2023-02-24","current":-1.152439,"twenty":-9.670972,"median":-7.620572,"eighty":-1.606597,"marketCap":73962369},{"date":"2023-03-03","current":-1.570917,"twenty":-9.670972,"median":-7.620572,"eighty":-1.580661,"marketCap":72846553},{"date":"2023-03-10","current":-1.201289,"twenty":-9.670972,"median":-7.610609,"eighty":-1.558614,"marketCap":55706187},{"date":"2023-03-17","current":-1.041677,"twenty":-9.670972,"median":-7.590746,"eighty":-1.531324,"marketCap":48304666},{"date":"2023-03-24","current":-0.898867,"twenty":-9.670972,"median":-7.586599,"eighty":-1.45222,"marketCap":41682252},{"date":"2023-03-31","current":-0.94087,"twenty":-9.669751,"median":-7.58433,"eighty":-1.382927,"marketCap":43630021},{"date":"2023-04-06","current":-0.890466,"twenty":-9.669751,"median":-7.582522,"eighty":-1.36419,"marketCap":41292698},{"date":"2023-04-14","current":-1.008075,"twenty":-9.670972,"median":-7.582522,"eighty":-1.323507,"marketCap":46746451},{"date":"2023-04-21","current":-1.253931,"twenty":-9.670972,"median":-7.582522,"eighty":-1.308256,"marketCap":41729568},{"date":"2023-04-28","current":-1.125022,"twenty":-9.670972,"median":-7.570231,"eighty":-1.293534,"marketCap":37439613},{"date":"2023-05-05","current":-1.054708,"twenty":-9.670972,"median":-7.56517,"eighty":-1.262094,"marketCap":35099637},{"date":"2023-05-12","current":-1.183617,"twenty":-9.670972,"median":-7.56517,"eighty":-1.252863,"marketCap":39389592},{"date":"2023-05-19","current":-1.207055,"twenty":-9.670972,"median":-7.56517,"eighty":-1.240995,"marketCap":40169584},{"date":"2023-05-26","current":-1.218774,"twenty":-9.670972,"median":-7.56447,"eighty":-1.236417,"marketCap":40559580},{"date":"2023-06-02","current":-1.26565,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":42119564},{"date":"2023-06-09","current":-1.417997,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":47189512},{"date":"2023-06-16","current":-1.406278,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":46799516},{"date":"2023-06-23","current":-1.406278,"twenty":-9.666612,"median":-7.558062,"eighty":-1.2256,"marketCap":46799516},{"date":"2023-06-30","current":-1.488311,"twenty":-9.625615,"median":-7.541992,"eighty":-1.224177,"marketCap":49529488},{"date":"2023-07-07","current":-1.324245,"twenty":-9.59294,"median":-7.541173,"eighty":-1.224177,"marketCap":44069544},{"date":"2023-07-14","current":-1.324245,"twenty":-9.527072,"median":-7.523385,"eighty":-1.224177,"marketCap":44069544},{"date":"2023-07-21","current":-1.26565,"twenty":-9.498536,"median":-7.491871,"eighty":-1.224177,"marketCap":42119564},{"date":"2023-07-28","current":-1.195336,"twenty":-9.463887,"median":-7.460598,"eighty":-1.218774,"marketCap":39779588},{"date":"2023-08-04","current":-1.183617,"twenty":-9.434142,"median":-7.43501,"eighty":-1.207055,"marketCap":39389592},{"date":"2023-08-11","current":-1.160179,"twenty":-9.407958,"median":-7.3852,"eighty":-1.201289,"marketCap":38609601},{"date":"2023-08-18","current":-1.14846,"twenty":-9.407958,"median":-7.378691,"eighty":-1.195336,"marketCap":38219605},{"date":"2023-08-25","current":-1.089865,"twenty":-9.407958,"median":-7.362612,"eighty":-1.188832,"marketCap":36269625},{"date":"2023-09-01","current":-1.054708,"twenty":-9.407958,"median":-7.356852,"eighty":-1.183617,"marketCap":35099637},{"date":"2023-09-08","current":-1.078146,"twenty":-9.407958,"median":-7.342021,"eighty":-1.183617,"marketCap":35879629},{"date":"2023-09-15","current":-1.03127,"twenty":-9.34521,"median":-7.337925,"eighty":-1.171898,"marketCap":34319645},{"date":"2023-09-22","current":-0.972675,"twenty":-9.313335,"median":-7.297158,"eighty":-1.16457,"marketCap":32369665},{"date":"2023-09-29","current":-0.874822,"twenty":-9.240982,"median":-7.27836,"eighty":-1.151741,"marketCap":29113199},{"date":"2023-10-06","current":-0.91033,"twenty":-9.217485,"median":-7.259591,"eighty":-1.140308,"marketCap":30294886},{"date":"2023-10-13","current":-1.253931,"twenty":-9.205804,"median":-7.239403,"eighty":-1.1351,"marketCap":41729568},{"date":"2023-10-20","current":-1.218774,"twenty":-9.205804,"median":-7.235538,"eighty":-1.1351,"marketCap":40559580},{"date":"2023-10-27","current":-1.242212,"twenty":-9.209208,"median":-7.224676,"eighty":-1.13503,"marketCap":41339572},{"date":"2023-11-03","current":-1.078146,"twenty":-9.209208,"median":-7.208286,"eighty":-1.134538,"marketCap":35879629},{"date":"2023-11-10","current":-1.088107,"twenty":-9.209208,"median":-7.17486,"eighty":-1.125022,"marketCap":36211125},{"date":"2023-11-17","current":-1.094553,"twenty":-9.209208,"median":-7.14828,"eighty":-1.1144,"marketCap":36425623},{"date":"2023-11-24","current":-1.019551,"twenty":-9.147917,"median":-7.103719,"eighty":-1.109232,"marketCap":33929649},{"date":"2023-12-01","current":-1.001973,"twenty":-9.109429,"median":-7.053158,"eighty":-1.095491,"marketCap":33344655},{"date":"2023-12-08","current":-1.03127,"twenty":-9.097201,"median":-7.003635,"eighty":-1.088733,"marketCap":34319645},{"date":"2023-12-15","current":-1.089865,"twenty":-9.091899,"median":-6.948878,"eighty":-1.087152,"marketCap":36269625},{"date":"2023-12-22","current":-1.066427,"twenty":-9.091899,"median":-6.885419,"eighty":-1.081608,"marketCap":35489633},{"date":"2023-12-29","current":-1.028927,"twenty":-9.093583,"median":-6.875377,"eighty":-1.078076,"marketCap":34241646},{"date":"2024-01-05","current":-1.054708,"twenty":-9.095268,"median":-6.858339,"eighty":-1.077926,"marketCap":35099637},{"date":"2024-01-12","current":-0.996349,"twenty":-9.095268,"median":-6.840522,"eighty":-1.074265,"marketCap":33157496},{"date":"2024-01-19","current":-1.054708,"twenty":-9.096952,"median":-6.803887,"eighty":-1.066427,"marketCap":35099637},{"date":"2024-01-26","current":-1.043106,"twenty":-9.095268,"median":-6.79162,"eighty":-1.061982,"marketCap":34713541},{"date":"2024-02-02","current":-1.171898,"twenty":-9.095268,"median":-6.751703,"eighty":-1.061982,"marketCap":38999597},{"date":"2024-02-09","current":-1.623872,"twenty":-9.095268,"median":-6.670796,"eighty":-1.061982,"marketCap":44672720},{"date":"2024-02-16","current":-1.942974,"twenty":-9.095268,"median":-6.639575,"eighty":-1.061982,"marketCap":53451202},{"date":"2024-02-23","current":-1.517505,"twenty":-9.095268,"median":-6.607596,"eighty":-1.061982,"marketCap":41746559},{"date":"2024-03-01","current":-1.886244,"twenty":-9.093583,"median":-6.55367,"eighty":-1.062507,"marketCap":51890583},{"date":"2024-03-08","current":-4.21214,"twenty":-9.093583,"median":-6.502965,"eighty":-1.062507,"marketCap":115875963},{"date":"2024-03-15","current":-4.112864,"twenty":-9.093583,"median":-6.458528,"eighty":-1.062507,"marketCap":113144880},{"date":"2024-03-22","current":-4.226322,"twenty":-9.093583,"median":-6.420725,"eighty":-1.062507,"marketCap":116266118},{"date":"2024-03-28","current":-5.148171,"twenty":-9.093583,"median":-6.400805,"eighty":-1.062507,"marketCap":141626177},{"date":"2024-04-05","current":-3.687395,"twenty":-9.095268,"median":-6.347041,"eighty":-1.061982,"marketCap":101440237},{"date":"2024-04-12","current":-2.921551,"twenty":-9.095268,"median":-6.303807,"eighty":-1.061982,"marketCap":80371880},{"date":"2024-04-19","current":-2.552812,"twenty":-9.095268,"median":-6.283707,"eighty":-1.061982,"marketCap":70227856},{"date":"2024-04-26","current":-3.219379,"twenty":-9.093583,"median":-6.26634,"eighty":-1.062507,"marketCap":88565130},{"date":"2024-05-03","current":-3.063516,"twenty":-9.093583,"median":-6.253291,"eighty":-1.062507,"marketCap":84277329},{"date":"2024-05-10","current":-3.304473,"twenty":-9.093583,"median":-6.253291,"eighty":-1.062507,"marketCap":90906059},{"date":"2024-05-17","current":-4.022089,"twenty":-9.093583,"median":-6.162033,"eighty":-1.062507,"marketCap":110647677},{"date":"2024-05-24","current":-6.36688,"twenty":-9.093583,"median":-6.150673,"eighty":-1.062507,"marketCap":133870029},{"date":"2024-05-31","current":-4.881894,"twenty":-9.093583,"median":-6.111473,"eighty":-1.062507,"marketCap":102646698},{"date":"2024-06-07","current":-4.529209,"twenty":-9.093583,"median":-5.991392,"eighty":-1.062507,"marketCap":95231157},{"date":"2024-06-14","current":-4.900456,"twenty":-9.093583,"median":-5.119806,"eighty":-1.062507,"marketCap":103036990},{"date":"2024-06-21","current":-4.69627,"twenty":-9.065467,"median":-5.074578,"eighty":-1.061982,"marketCap":98743782},{"date":"2024-06-28","current":-4.45496,"twenty":-9.049757,"median":-4.938699,"eighty":-1.061982,"marketCap":93669991},{"date":"2024-07-05","current":-4.547772,"twenty":-9.034297,"median":-4.866118,"eighty":-1.061982,"marketCap":95621449},{"date":"2024-07-12","current":-4.343586,"twenty":-9.027495,"median":-4.646187,"eighty":-1.061982,"marketCap":91328241},{"date":"2024-07-19","current":-4.083713,"twenty":-9.008296,"median":-4.566515,"eighty":-1.061982,"marketCap":85864158},{"date":"2024-07-26","current":-3.647499,"twenty":-9.008296,"median":-4.482804,"eighty":-1.061982,"marketCap":76692305},{"date":"2024-08-02","current":-3.434032,"twenty":-9.005363,"median":-4.402793,"eighty":-1.061982,"marketCap":72203951},{"date":"2024-08-09","current":-3.601093,"twenty":-8.998216,"median":-4.325024,"eighty":-1.061982,"marketCap":75716576},{"date":"2024-08-16","current":-3.471156,"twenty":-8.984285,"median":-4.268869,"eighty":-1.061982,"marketCap":72984534},{"date":"2024-08-23","current":-3.563968,"twenty":-8.966097,"median":-4.219986,"eighty":-1.061982,"marketCap":74935992},{"date":"2024-08-30","current":-5.280878,"twenty":-8.938391,"median":-4.194332,"eighty":-1.061982,"marketCap":82212714},{"date":"2024-09-06","current":-5.099672,"twenty":-8.913084,"median":-4.194332,"eighty":-1.061982,"marketCap":79391689},{"date":"2024-09-13","current":-5.953931,"twenty":-8.88535,"median":-4.194332,"eighty":-1.061982,"marketCap":92690805},{"date":"2024-09-20","current":-5.513858,"twenty":-8.862512,"median":-4.194332,"eighty":-1.061982,"marketCap":85839745},{"date":"2024-09-27","current":-5.695065,"twenty":-8.83563,"median":-4.194332,"eighty":-1.061982,"marketCap":88660770},{"date":"2024-10-04","current":-6.135138,"twenty":-8.820265,"median":-4.194332,"eighty":-1.061982,"marketCap":95511829},{"date":"2024-10-11","current":-6.445778,"twenty":-8.804634,"median":-4.194332,"eighty":-1.061982,"marketCap":100347871},{"date":"2024-10-18","current":-6.057478,"twenty":-8.774324,"median":-4.194332,"eighty":-1.061982,"marketCap":94302819},{"date":"2024-10-25","current":-5.850385,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":91078791},{"date":"2024-11-01","current":-5.772725,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":89869780},{"date":"2024-11-08","current":-5.022012,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":78182679},{"date":"2024-11-15","current":-4.193639,"twenty":-8.734517,"median":-4.185082,"eighty":-1.061982,"marketCap":65286567},{"date":"2024-11-22","current":-4.504279,"twenty":-8.725745,"median":-4.185082,"eighty":-1.061982,"marketCap":70122609},{"date":"2024-11-29","current":-4.996125,"twenty":-8.713034,"median":-4.185082,"eighty":-1.061982,"marketCap":77779675},{"date":"2024-12-06","current":-4.400732,"twenty":-8.69392,"median":-4.185082,"eighty":-1.061982,"marketCap":68510595},{"date":"2024-12-13","current":-4.245412,"twenty":-8.668422,"median":-4.173059,"eighty":-1.061982,"marketCap":66092574},{"date":"2024-12-20","current":-4.115979,"twenty":-8.623519,"median":-4.114422,"eighty":-1.061982,"marketCap":64077556},{"date":"2024-12-27","current":-4.180695,"twenty":-8.596523,"median":-4.114422,"eighty":-1.061982,"marketCap":65085065},{"date":"2025-01-03","current":-4.219525,"twenty":-8.568166,"median":-4.114422,"eighty":-1.061982,"marketCap":65689570},{"date":"2025-01-10","current":-4.297185,"twenty":-8.543875,"median":-4.112864,"eighty":-1.061457,"marketCap":66898581},{"date":"2025-01-17","current":-4.452505,"twenty":-8.475638,"median":-4.112864,"eighty":-1.061457,"marketCap":69316602},{"date":"2025-01-24","current":-4.426619,"twenty":-8.440174,"median":-4.112864,"eighty":-1.061457,"marketCap":68913598},{"date":"2025-01-31","current":-4.633712,"twenty":-8.413839,"median":-4.112864,"eighty":-1.061457,"marketCap":72137626},{"date":"2025-02-07","current":-4.323072,"twenty":-8.379544,"median":-4.112864,"eighty":-1.061457,"marketCap":67301584},{"date":"2025-02-14","current":-4.426877,"twenty":-8.325638,"median":-4.112864,"eighty":-1.061457,"marketCap":68917628},{"date":"2025-02-21","current":-4.633712,"twenty":-8.280104,"median":-4.112864,"eighty":-1.061457,"marketCap":72137626},{"date":"2025-02-28","current":-4.374845,"twenty":-8.216736,"median":-4.112864,"eighty":-1.061457,"marketCap":68107591},{"date":"2025-03-07","current":-4.323072,"twenty":-8.165465,"median":-4.112864,"eighty":-1.06142,"marketCap":67301584},{"date":"2025-03-14","current":-4.505832,"twenty":-8.144499,"median":-4.112864,"eighty":-1.06142,"marketCap":70146789},{"date":"2025-03-21","current":-4.141865,"twenty":-8.099624,"median":-4.112864,"eighty":-1.06142,"marketCap":64480560},{"date":"2025-03-28","current":-5.21941,"twenty":-8.029949,"median":-4.052901,"eighty":-1.06142,"marketCap":58055500},{"date":"2025-04-04","current":-4.856951,"twenty":-7.975726,"median":-4.052901,"eighty":-1.06142,"marketCap":54023868},{"date":"2025-04-11","current":-3.98705,"twenty":-7.904381,"median":-4.017609,"eighty":-1.061457,"marketCap":44347952},{"date":"2025-04-17","current":-4.748214,"twenty":-7.829624,"median":-4.017609,"eighty":-1.061457,"marketCap":52814379},{"date":"2025-04-25","current":-5.799345,"twenty":-7.762945,"median":-4.016303,"eighty":-1.06142,"marketCap":64506112},{"date":"2025-05-02","current":-6.125558,"twenty":-7.734259,"median":-4.016303,"eighty":-1.06142,"marketCap":68134580},{"date":"2025-05-09","current":-6.089312,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-05-16","current":-19.597391,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":66925091},{"date":"2025-05-23","current":-19.833504,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-05-30","current":-20.561913,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":70218934},{"date":"2025-06-06","current":-19.833504,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-06-13","current":-33.41001,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":114095185},{"date":"2025-06-20","current":-36.715594,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":125383755},{"date":"2025-06-27","current":-29.750257,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":101597126},{"date":"2025-07-03","current":-26.326616,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":89905393},{"date":"2025-07-11","current":-26.562729,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":90711720},{"date":"2025-07-18","current":-25.972446,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":88695904},{"date":"2025-07-25","current":-23.021032,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":78616824},{"date":"2025-08-01","current":-24.201598,"twenty":-7.735622,"median":-4.014996,"eighty":-1.061383,"marketCap":82648456},{"date":"2025-08-08","current":-24.087125,"twenty":-7.765539,"median":-4.014996,"eighty":-1.061383,"marketCap":82257532},{"date":"2025-08-15","current":-68.124339,"twenty":-7.829624,"median":-4.014996,"eighty":-1.061383,"marketCap":81067963},{"date":"2025-08-22","current":-59.651162,"twenty":-7.867699,"median":-4.014996,"eighty":-1.061383,"marketCap":70984883},{"date":"2025-08-29","current":-61.006871,"twenty":-7.942625,"median":-4.014996,"eighty":-1.061383,"marketCap":72598176},{"date":"2025-09-05","current":-62.362578,"twenty":-8.008083,"median":-4.013714,"eighty":-1.061345,"marketCap":74211468},{"date":"2025-09-12","current":-63.37936,"twenty":-8.051793,"median":-4.014996,"eighty":-1.061383,"marketCap":75421438},{"date":"2025-09-19","current":-58.295454,"twenty":-8.051793,"median":-4.014996,"eighty":-1.061383,"marketCap":69371590},{"date":"2025-09-26","current":-56.939745,"twenty":-8.138933,"median":-4.014996,"eighty":-1.061383,"marketCap":67758297},{"date":"2025-10-03","current":-58.634381,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":69774913},{"date":"2025-10-10","current":-61.345797,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":73001499},{"date":"2025-10-17","current":-60.49848,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":71993191},{"date":"2025-10-24","current":-68.463266,"twenty":-8.295661,"median":-4.014996,"eighty":-1.061383,"marketCap":81471286},{"date":"2025-10-31","current":-64.735068,"twenty":-8.295661,"median":-4.014996,"eighty":-1.061383,"marketCap":77034731},{"date":"2025-11-07","current":-65.073995,"twenty":-8.317462,"median":-4.014996,"eighty":-1.061383,"marketCap":77438054},{"date":"2025-11-14","current":-69.818974,"twenty":-8.317462,"median":-4.014996,"eighty":-1.061383,"marketCap":83084579},{"date":"2025-11-21","current":-117.35491,"twenty":-8.403551,"median":-4.014996,"eighty":-1.061383,"marketCap":70178236},{"date":"2025-11-28","current":-145.784813,"twenty":-8.440594,"median":-4.014996,"eighty":-1.061383,"marketCap":87179318},{"date":"2025-12-05","current":-132.719192,"twenty":-8.503786,"median":-4.014996,"eighty":-1.061383,"marketCap":79366077},{"date":"2025-12-12","current":-149.910798,"twenty":-8.562452,"median":-4.014996,"eighty":-1.061383,"marketCap":89646657},{"date":"2025-12-19","current":-128.593207,"twenty":-8.61847,"median":-4.014996,"eighty":-1.061383,"marketCap":76898738},{"date":"2025-12-26","current":-132.031528,"twenty":-8.683631,"median":-4.014996,"eighty":-1.061383,"marketCap":78954854},{"date":"2026-01-02","current":-112.089266,"twenty":-8.713986,"median":-4.014996,"eighty":-1.061383,"marketCap":67029381},{"date":"2026-01-09","current":-109.338609,"twenty":-8.744078,"median":-4.014996,"eighty":-1.061383,"marketCap":65384488},{"date":"2026-01-16","current":-121.716565,"twenty":-8.744078,"median":-4.014996,"eighty":-1.061383,"marketCap":72786506},{"date":"2026-01-23","current":-114.839923,"twenty":-8.776229,"median":-4.014996,"eighty":-1.061383,"marketCap":68674274},{"date":"2026-01-30","current":-107.275617,"twenty":-8.801379,"median":-4.014996,"eighty":-1.061383,"marketCap":64150819},{"date":"2026-02-06","current":-105.900288,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":63328372},{"date":"2026-02-13","current":-94.209997,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":56337578},{"date":"2026-02-20","current":-90.771676,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":54281462},{"date":"2026-02-27","current":-89.396348,"twenty":-8.847106,"median":-4.014996,"eighty":-1.061383,"marketCap":53459016},{"date":"2026-03-06","current":-102.461967,"twenty":-8.978573,"median":-4.014996,"eighty":-1.061383,"marketCap":61272256},{"date":"2026-03-13","current":-112.089266,"twenty":-9.171771,"median":-4.014996,"eighty":-1.061383,"marketCap":67029381},{"date":"2026-03-20","current":-107.275617,"twenty":-9.560454,"median":-4.014996,"eighty":-1.061383,"marketCap":64150819},{"date":"2026-03-27","current":-65.812063,"twenty":-12.877976,"median":-4.014996,"eighty":-1.061383,"marketCap":66206935},{"date":"2026-04-02","current":-69.895519,"twenty":-13.201682,"median":-4.014996,"eighty":-1.061383,"marketCap":70314892},{"date":"2026-04-10","current":-72.347993,"twenty":-13.956876,"median":-4.014996,"eighty":-1.061383,"marketCap":72782081},{"date":"2026-04-17","current":-68.669281,"twenty":-14.862192,"median":-4.014996,"eighty":-1.061383,"marketCap":69081297},{"date":"2026-04-24","current":-67.85179,"twenty":-16.29052,"median":-4.014996,"eighty":-1.061383,"marketCap":68258901},{"date":"2026-05-01","current":-62.137525,"twenty":-17.553263,"median":-4.014996,"eighty":-1.061383,"marketCap":62510350},{"date":"2026-05-08","current":-58.041893,"twenty":-19.337667,"median":-4.014996,"eighty":-1.061383,"marketCap":58390144},{"date":"2026-05-15","current":-7.909727,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":60446135},{"date":"2026-05-22","current":-7.748304,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":59212540},{"date":"2026-05-29","current":-9.254919,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":70726090},{"date":"2026-06-05","current":-9.201111,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":70314892},{"date":"2026-06-12","current":-8.878265,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":67847703},{"date":"2026-06-18","current":-8.555419,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":65380513},{"date":"2026-06-26","current":-8.609227,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":65791712},{"date":"2026-07-02","current":-9.954419,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":76071667},{"date":"2026-07-10","current":-8.017342,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":61268531},{"date":"2026-07-17","current":-6.887381,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":52633369},{"date":"2026-07-24","current":-5.811228,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":44409405},{"date":"2026-07-31","current":-6.080266,"twenty":-19.773511,"median":-4.012432,"eighty":-1.061308,"marketCap":46465396},{"date":"2026-08-07","current":-4.681267,"twenty":-19.773511,"median":-4.012432,"eighty":-1.061308,"marketCap":35774243},{"date":"2026-08-14","current":-5.360858,"twenty":-19.773511,"median":-4.012432,"eighty":-1.061308,"marketCap":40967676},{"date":"2026-08-21","current":-4.429377,"twenty":-19.773511,"median":-4.012432,"eighty":-1.061308,"marketCap":29610382},{"date":"2026-08-28","current":-3.937907,"twenty":-19.773511,"median":-4.010102,"eighty":-1.061308,"marketCap":26324908},{"date":"2026-09-04","current":-3.827188,"twenty":-19.691837,"median":-3.950804,"eighty":-1.061308,"marketCap":25584752},{"date":"2026-09-11","current":-4.716631,"twenty":-19.691837,"median":-3.86717,"eighty":-1.061308,"marketCap":31530677},{"date":"2026-09-18","current":-4.35987,"twenty":-19.691837,"median":-3.86717,"eighty":-1.061308,"marketCap":29145728},{"date":"2026-09-25","current":-4.459517,"twenty":-19.691837,"median":-3.86717,"eighty":-1.061308,"marketCap":29811869},{"date":"2026-09-29","current":-6.889184,"twenty":-19.691837,"median":-3.86717,"eighty":-1.061308,"marketCap":46054198}],"updateTime":1790821003199},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BYSI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640517251","title":"Beyondspring - Appoints Na Li as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640517251","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640517251?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA3HNWKC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640151787","title":"Beyondspring - Appoints Min Qiu as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640151787","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640151787?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA3HNWKC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640151723","title":"Beyondspring - Lan Huang Remains Chairman of Beyondspring, Focuses Executive Duties on Seed Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2640151723","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640151723?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA3HNWKC:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640015170","title":"Beyondspring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory Dublin-4 Program and Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2640015170","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640015170?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA3HNWKC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640424151","title":"Press Release: BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2640424151","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640424151?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570800,"startTime":"0","endTime":"0","summary":"-- Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time. to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief. Executive Officer -- a structure designed to give each company a fully. -- Dr. Jiangwen  Majeti, PhD, MBA, current BeyondSpring Director,appointed Vice Chairman -- deepening Board-level governance and providing. -- Min Qiu appointed Chief Executive Officer with a clear mandate: execute. financial position and support capital markets engagement with Asian and. Plinabulin is a first-in-class GEF-H1 agonist whose multifunctional mechanism -- encompassing dendritic cell maturation, tumor microenvironment modulation, anti-angiogenesis, and neutropenia mitigation -- activates biological pathways that standard chemotherapy and ADC drugs do not. BeyondSpring's intellectual property portfolio protecting Plinabulin includes patents granted across 40+ jurisdictions globally, with U.S. composition-of-matter protection currently extending through 2","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4139","ADC","BK4231","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640973102","title":"BeyondSpring publishes corporate deck highlighting plinabulin immune-modulating cancer therapy pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2640973102","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640973102?lang=en_us&edition=fundamental","pubTime":"2026-06-03 12:15","pubTimestamp":1780460146,"startTime":"0","endTime":"0","summary":"BeyondSpring highlighted Phase 3 Dublin-3 data in 2L/3L EGFR wild-type NSCLC: median OS 10.5 months vs 9.4; HR 0.82; p=0.0399.Dublin-3 showed lower grade 4 neutropenia on day 8 across all cycles: 22.3% vs 43.5% for docetaxel alone.Post-hoc non-squamous subgroup: median OS 11.37 months vs 8.81; HR 0.72; p=0.0078.Mechanism-enriched post-PD-1/L1 subgroup: median OS 15.8 months vs 11.7; HR 0.55; p=0.076.Planned Dublin-4 confirmatory Phase 3 in non-squamous NSCLC progressed on PD-1/L1 with PFS at least 3 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL2Zw1Mb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917843","title":"Beyondspring - Reports 12-Month Os Rate of 78.1%, 24-Month Os Rate of 58% in Phase 2 Nsclc Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917843?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:04","pubTimestamp":1780398298,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A06Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917384","title":"Beyondspring - 53.2% of Patients Experienced Grade 3 or Higher Adverse Events in Phase 2 Nsclc Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917384","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917384?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:04","pubTimestamp":1780398298,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A06Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640912005","title":"Beyondspring - Reports Median Pfs of 7 Months, Dcr of 79.5% in Phase 2 Nsclc Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640912005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640912005?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:04","pubTimestamp":1780398298,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A06Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917836","title":"BeyondSpring says Phase 2 trial shows 7-month median PFS for pembrolizumab plus plinabulin/docetaxel in post-ICI metastatic NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917836","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917836?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:03","pubTimestamp":1780398218,"startTime":"0","endTime":"0","summary":"BeyondSpring reported updated Phase 2 results at ASCO 2026 for pembrolizumab, plinabulin, docetaxel in metastatic NSCLC progressing on first-line ICI therapy.Data showed sustained tumor control with responses that generally held up over time in a post-ICI setting with limited options.Survival outcomes remained strong at 12 months and 24 months, with the study not yet reaching a midpoint survival estimate.Safety looked manageable, with a meaningful share of patients reporting serious treatment-related side effects, including blood count-related events.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL9Ldqrb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","SG9999014005.SGD","BK4112","BYSI","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014021.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640175949","title":"BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640175949","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640175949?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398000,"startTime":"0","endTime":"0","summary":"Meaningful clinical benefit: Median PFS at 7.0 months, median DoR is 9.3 months with DCR of 79.5% in metastatic NSCLC patients with acquired resistance to immune checkpoint inhibitorsDurable survival ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3304984/0/en/BeyondSpring-Presents-the-Latest-Update-of-a-Phase-2-Study-Demonstrating-Durable-Clinical-Benefit-of-Pembrolizumab-Plus-Plinabulin-Docetaxel-in-Metastatic-NSCLC-After-Progression-o.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","LU0210528500.USD","ADC","LU0053666078.USD","ORR","BK4139","BK4211","LU2487616109.SGD","AR","BK4195","BK4588","BK4231","BK4213","BYSI","L","PFS","BK4107","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636027107","title":"BeyondSpring to present Phase 2 plinabulin combo study in resistant NSCLC at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636027107","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636027107?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:02","pubTimestamp":1779102157,"startTime":"0","endTime":"0","summary":"BeyondSpring flagged new Phase 2 data from Study 303 in metastatic non-small cell lung cancer patients whose disease progressed on PD-1/PD-L1 inhibitors, with results scheduled for future presentation at the 2026 ASCO Annual Meeting.The poster will cover efficacy and immune profiling for a regimen combining plinabulin, docetaxel, and pembrolizumab in second- or third-line treatment.Disclosure at ASCO is set for May 31, 2026, in a lung cancer session in Chicago.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL372zj5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2210149790.SGD","BK4139","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","NDAQ","IE00BN0W2T93.GBP","SG9999014005.SGD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","BYSI","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636027291","title":"BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2636027291","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636027291?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:00","pubTimestamp":1779102000,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., May  18, 2026  (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing transformative therapies for the treatmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3296480/0/en/BeyondSpring-Announces-Poster-Presentation-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["L","LU0053666078.USD","BK4585","AR","BK4139","BK4107","BK4213","BYSI","BK4588","LU0210528500.USD","LU2487616109.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635899347","title":"BeyondSpring Q1 EPS $(0.05) Up From $(0.06) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635899347","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635899347?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:23","pubTimestamp":1778671411,"startTime":"0","endTime":"0","summary":"BeyondSpring (NASDAQ:BYSI) reported quarterly losses of $(0.05) per share. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52518190/beyondspring-q1-eps-0-05-up-from-0-06-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPIQ","PSQ","QQQ","ONEQ",".IXIC","QDTE","NQmain","QYLG","QID","QQQE","BYSI","QQQA","NDX","TQQY","QLD","FTEC","TECS","JEPQ","MNQmain","BK4139","SQQQ","QQQY","QQQM","TQQQ","QQQJ","NVIW.SI","IYW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786148","title":"BeyondSpring Q1 FY26 net loss narrows to $2.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786148","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786148?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:05","pubTimestamp":1778670305,"startTime":"0","endTime":"0","summary":"BeyondSpring posted a net loss of USD 2.4 million for the quarter ended March 31, 2026, narrowing from a net loss of USD 2.6 million a year earlier.R&D expenses rose 22.22% to USD 1.1 million, while G&A expenses dropped 35.29% to USD 1.1 million.Cash, cash equivalents, and short-term investments totaled USD 7.9 million as of March 31, 2026.Discontinued operations swung to a net loss of USD 4.3 million from net income of USD 3.8 million a year earlier; current assets were USD 5.3 million as of March 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securiti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDLc34p7v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635869337","title":"BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635869337","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635869337?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:00","pubTimestamp":1778670000,"startTime":"0","endTime":"0","summary":"AACR 2026 Data Positions Plinabulin as a Potential Backbone Agent to Combine with Antibody-Drug Conjugate (ADC)-Based Therapies to Improve Anti-Cancer Efficacy and Tolerability SEED Advances First Mol","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293842/0/en/BeyondSpring-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","ADC","BK4231","BK4080","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629076662","title":"BeyondSpring publishes corporate presentation on plinabulin immune-modulating cancer therapy pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629076662?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:07","pubTimestamp":1776895622,"startTime":"0","endTime":"0","summary":"BeyondSpring investor deck highlighted plinabulin as lead late-stage asset, positioning it as a first-in-class, reversible tubulin depolymerizing agent with immune-modulating activity.DUBLIN-3 Phase 3 trial in 2L/3L NSCLC EGFR wild type reported overall survival benefit for plinabulin + docetaxel vs docetaxel, with OS HR 0.82.Study showed median OS 10.5 months for plinabulin + docetaxel vs 9.4 months for docetaxel.Safety readout cited grade 4 neutropenia reduction on day 8 across all cycles, with 22.3% on plinabulin + docetaxel vs 43.5% on docetaxel.Pipeline update flagged SEED targeted protein degradation platform, with lead oral RBM39 degrader entering Phase 1.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. publishe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL65Gq5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010045","title":"BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010045","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010045?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":"New Preclinical Results at AACR 2026 Show Plinabulin Dramatically Improves Complete Response Rates and Survival When Combined with Leading ADC Drugs— With or Without Immunotherapy Plinabulin’s GEF-H1 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3278803/0/en/BeyondSpring-Reports-Compelling-New-Data-Plinabulin-Advances-Both-the-Anticancer-Efficacy-and-Safety-of-ADC-Drugs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139","ADC","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":38,"code":"91000000","status":"200"}]}}